Tara Lech/thrombosis.org
Feb 21, 2026, 12:41
Tara Lech: New Guidelines for Comprehensive, Evidence Based Management of PE
Tara Lech, Director of Anticoagulation Services at Beth Israel Lahey Health and Member Board of Directors at Anticoagulation Forum, shared a post LinkedIn:
“New guidelines for comprehensive, evidence based management of PE
Collaborated on and endorsed by 8 societies
What you will find:
- Acute PE Clinical Categories (A-E)
- Clearly defined risk factors to screen for during a targeted history and physical examination
- Overview of an effective PERT Team
- LMWH preferred over unfractionated Heparin for most patients
- Considerations for special populations (Obesity, Thrombotic APS, Brain Tumors, CKD, Pregnancy, Breastfeeding, Chronic Liver Disease)
- Recommendations for timing and utility of LMWH levels, noting Class III
Recommendation: No Benefit for most patients with acute PE ”
Stay updated with Hemostasis Today.
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’
-
Jul 7, 2026, 20:59William Aird: An Unlucky Turn Into the Renal Artery
-
Jul 7, 2026, 20:58Chokri Ben Lamine: The Two-Hit Model of TRALI
-
Jul 7, 2026, 20:57New Issue of Blood Out Now – Blood Journals Portfolio
-
Jul 7, 2026, 20:56Priyadarshini Ramakrishnan: Schistocytes – The Most “Misleading Heroes” in a Peripheral Smear